Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

European study of Progenta for uterine fibroids

July 5, 2004

Novel DPP-IV inhibitors in early development at Merck

July 5, 2004

Exenatide NDA submission for type 2 diabetes

July 2, 2004

New MCH receptor modulators in early development at Tularik

July 2, 2004

Novel SERM with minimal ovarian effects

July 2, 2004

Preclinical evidence for the effects of rimonabant on body weight and food intake

July 1, 2004

Approvable letter for oxypurinol for allopurinol-intolerant hyperuricemia

July 1, 2004

Servier presents new AMPK activators with potential in diabetes and other disorders

July 1, 2004

Manhattan Pharmaceuticals investigates oleoyl estrone for weight control

July 1, 2004

French researchers identify new protein kinase modulators for diabetes, cancer, etc.

July 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...